Sundlof said her connection to the Bangkok speaking opportunity started with a prior conversation she had with a cardiologist in Bangkok who was performing transcatheter aortic valve replacement (TAVR) on her uncle. During their discussions, she discovered he was her junior fellow at Albert Einstein Medical Center in Philadelphia. “One thing led to another, and I was asked to speak at their Department of Medicine grand rounds on Nov. 30,” Sundlof says. “Interestingly, my mother went to medical school at Siriraj and Mahidol in the 1950s.”
Sundlof gave her presentation – Cardio-Oncology: An Introduction – to about 150 physicians, fellows and residents of all medical disciplines. She says there are currently no cardio-oncologists in Thailand.
“My talk was well-received and there were a lot of questions,” Sundlof says. “They’ve identified a senior cardiology fellow who will start the first cardio-oncology program at Siriraj. I connected them with the International Cardio-Oncology Society and will continue to serve as an expert mentor for their program.”
Certain cancer treatments can weaken heart muscle, a condition known as cardiotoxicity. It can raise blood pressure, or cause the heart to beat out of sync, a condition known as arrhythmia. The goal of the Heart and Vascular Institute’s cardio-oncology program is to minimize or prevent heart-related problems due to cancer treatments.
LVHN’s cardio-oncology program earlier this year received a gold-level Center of Excellence designation from the International Cardio-Oncology Society. Less than three dozen centers of excellence worldwide have a gold level designation.